A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine

Nicotine and Tobacco Research

Volumn 15, Issue 7, 2013, Pages 1297-1304

  Chisolm, Margaret S ^a   Fitzsimons, Heather ^a   Leoutsakos, Jeannie Marie S ^a,b   Acquavita, Shauna P ^c   Heil, Sarah H ^d   Wilson Murphy, Molly ^a   Tuten, Michelle ^a   Kaltenbach, Karol ^e   Martin, Peter R ^f   Winklbaur, Bernadette ^g   Jansson, Lauren M ^a   Jones, Hendrée E ^a,h  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE;

ADDICTION SEVERITY INDEX; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OPIATE ADDICTION; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; BUPRENORPHINE; FEMALE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; SMOKING; YOUNG ADULT;

EID: 84879333011     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts274     Document Type: Article

References (57)

1. Baca, C. T., & Yahne, C. E. (2009). Smoking cessation during substance abuse treatment: What you need to know. Journal of Substance Abuse Treatment, 36, 205-219. doi:10.1016/j. jsat.2008.06.003
2. Bada, H. S., Das, A., Bauer, C. R., Shankaran, S., Lester, B. M., Gard, C. C., . . . Higgins, R. (2005). Low birth weight and preterm births: Etiologic fraction attributable to prenatal drug exposure. Journal of Perinatology, 25, 631-637. doi:10.1038/sj.jp.7211378
3. Bailey, G. P., & Marien, D. (2011). The value of juvenile animal studies "what have we learned from preclinical juvenile toxicity studies? II". Birth Defects Research.Part B, Developmental and Reproductive Toxicology, 92, 273-291. doi:10.1002/bdrb.20328; 10.1002/bdrb.20328
4. Ball, S. A., Rounsaville, B. J., Tennen, H., & Kranzler, H. R. (2001). Reliability of personality disorder symptoms and personality traits in substance-dependent inpatients. Journal of Abnormal Psychology, 110, 341-352.
5. Burstyn, I., Kapur, N., Shalapay, C., Bamforth, F., Wild, T. C., Liu, J., & LeGatt, D. (2009). Evaluation of the accuracy of self-reported smoking in pregnancy when the biomarker level in an active smoker is uncertain. Nicotine & Tobacco Research, 11, 670-678. doi:10.1093/ntr/ntp048
6. Centers for Disease Control and Prevention (CDC). (2008a). Smoking prevalence among women of reproductive age-- united states, 2006. MMWR.Morbidity and Mortality Weekly Report, 57, 849-852.
7. Centers for Disease Control and Prevention (CDC). (2008b). Smoking-attributable mortality, years of potential life lost, and productivity losses--united states, 2000-2004. MMWR. Morbidity and Mortality Weekly Report, 57, 1226-1228.
8. Chait, L. D., & Griffiths, R. R. (1984). Effects of methadone on human cigarette smoking and subjective ratings. Journal of Pharmacology and Experimental Therapeutics, 229, 636-640.
9. Chisolm, M. S., Brigham, E. P., Lookatch, S. J., Tuten, M., Strain, E. C., & Jones, H. E. (2010). Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center. Journal of Substance Abuse Treatment, 39, 298-305. doi:10.1016/j. jsat.2010.06.008
10. Chisolm, M. S., Brigham, E. P., Tuten, M., Strain, E. C., & Jones, H. E. (2010). The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. American Journal of Drug and Alcohol Abuse, 36, 46-51. doi:10.3109/00952990903544844
11. Chisolm, M. S., Tuten, M., Brigham, E. C., Strain, E. C., & Jones, H. E. (2009). Relationship between cigarette use and mood/ anxiety disorders among pregnant methadone-maintained patients. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 18, 422-429. doi:10.3109/10550490903077721
12. Choo, R. E., Huestis, M. A., Schroeder, J. R., Shin, A. S., & Jones, H. E. (2004). Neonatal abstinence syndrome in methadone- exposed infants is altered by level of prenatal tobacco exposure. Drug and Alcohol Dependence, 75, 253-260.
13. Cnattingius, S. (2004). The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine & Tobacco Research, 6(Suppl. 2), S125-S140. doi:10.1080/14622200410001669 187
14. Conter, V., Cortinovis, I., Rogari, P., & Riva, L. (1995). Weight growth in infants born to mothers who smoked during pregnancy. British Medical Journal (Clinical research ed.), 310, 768-771.
15. Dietz, P. M., England, L. J., Shapiro-Mendoza, C. K., Tong, V. T., Farr, S. L., & Callaghan, W. M. (2010). Infant morbidity and mortality attributable to prenatal smoking in the U.S. American Journal of Preventive Medicine, 39, 45-52. doi:10.1016/j.amepre.2010.03.009
16. Dolan-Mullen, P., Ramírez, G., & Groff, J. Y. (1994). A metaanalysis of randomized trials of prenatal smoking cessation interventions. American Journal of Obstetrics and Gynecology, 171, 1328-1334.
17. D'Onofrio, B. M., Turkheimer, E. N., Eaves, L. J., Corey, L. A., Berg, K., Solaas, M. H., & Emery, R. E. (2003). The role of the children of twins design in elucidating causal relations between parent characteristics and child outcomes. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 44, 1130-1144.
18. Dupont, W. D., & Plummer, W. D., Jr. (1990). Power and sample size calculations. A review and computer program. Controlled clinical trials, 11, 116-128.
19. Elkader, A. K., Brands, B., Selby, P., & Sproule, B. A. (2009). Methadone-nicotine interactions in methadone maintenance treatment patients. Journal of Clinical Psychopharmacology, 29, 231-238. doi:10.1097/JCP.0b013e3181a39113
20. Fiore, M. C., & Jaen, C. R. (2008). A clinical blueprint to accelerate the elimination of tobacco use. JAMA: The Journal of the American Medical Association, 299, 2083-2085. doi:10.1001/jama.299.17.2083
21. Floyd, R. L., Rimer, B. K., Giovino, G. A., Mullen, P. D., & Sullivan, S. E. (1993). A review of smoking in pregnancy: Effects on pregnancy outcomes and cessation efforts. Annual Review of Public Health, 14, 379-411. doi:10.1146/annurev. pu.14.050193.002115
22. Friedmann, P. D., Jiang, L., & Richter, K. P. (2008). Cigarette smoking cessation services in outpatient substance abuse treatment programs in the united states. Journal of Substance Abuse Treatment, 34, 165-172. doi:10.1016/j. jsat.2007.02.006
23. Fuller, B. E., Guydish, J., Tsoh, J., Reid, M. S., Resnick, M., Zammarelli, L., . . . McCarty, D. (2007). Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. Journal of Substance Abuse Treatment, 32, 53-60. doi:10.1016/j.jsat.2006.06.011
24. Haug, N. A., Stitzer, M. L., & Svikis, D. S. (2001). Smoking during pregnancy and intention to quit: A profile of methadone- maintained women. Nicotine & Tobacco Research, 3, 333-339. doi:10.1080/14622200110050493
25. Heil, S. H., Higgins, S. T., Bernstein, I. M., Solomon, L. J., Rogers, R. E., Thomas, C. S., . . . Lynch, M. E. (2008). Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction (Abingdon, England), 103, 1009-1018. doi:10.1111/j.1360-0443.2008.02237.x
26. Henderson, R., Diggle, P., & Dobson, A. (2000). Joint modelling of longitudinal measurements and event time data. Biostatistics (Oxford, England), 1, 465-480. doi:10.1093/ biostatistics/1.4.465
27. Hurt, R. D., Offord, K. P., Croghan, I. T., Gomez-Dahl, L., Kottke, T. E., Morse, R. M., & Melton, L. J., 3rd. (1996). Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA: The Journal of the American Medical Association, 275, 1097-1103.
28. Jones, H. E., Heil, S. H., O'Grady, K. E., Martin, P. R., Kaltenbach, K., Coyle, M. G., . . . Fischer, G. (2009). Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. American Journal of Drug and Alcohol Abuse, 35, 375-380. doi:10.1080/00952990903125235
29. Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., . . . Fischer, G. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363, 2320-2331. doi:10.1056/NEJMoa1005359
30. Kawakami, N., Takatsuka, N., Inaba, S., & Shimizu, H. (1999). Development of a screening questionnaire for tobacco/ nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addictive Behaviors, 24, 155-166.
31. Knopik, V. S., Sparrow, E. P., Madden, P. A., Bucholz, K. K., Hudziak, J. J., Reich, W., & Heath, A. C. (2005). Contributions of parental alcoholism, prenatal substance exposure, and genetic transmission to child ADHD risk: A female twin study. Psychological Medicine, 35, 625-635.
32. Lacroix, I., Berrebi, A., Garipuy, D., Schmitt, L., Hammou, Y., Chaumerliac, C., . . . Damase-Michel, C. (2011). Buprenorphine versus methadone in pregnant opioid-dependent women: A prospective multicenter study. European Journal of Clinical Pharmacology, 67, 1053-1059. doi:10.1007/s00228-011-1049-9
33. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. JAMA: The Journal of the American Medical Association, 284, 2606-2610.
34. Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009). Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews (Online), 3, CD001055. doi:10.1002/14651858.CD001055.pub3
35. Martin, B. K., Meinert, C. L., & Breitner, J. C., & ADAPT Research Group. (2002). Double placebo design in a prevention trial for Alzheimer's disease. Controlled Clinical Trials, 23, 93-99.
36. McCowan, L., & Horgan, R. P. (2009). Risk factors for small for gestational age infants. Best Practice & Research.Clinical Obstetrics & Gynaecology, 23, 779-793. doi:10.1016/j. bpobgyn.2009.06.003
37. McLellan, A. T., Cacciola, J., Alterman, A. I., Rikoon, S. H., & Carise, D. (2006). The addiction severity index at 25: Origins, contributions and transitions. American Journal of Addiction, 15, 113-124.
38. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., . . . Argeriou, M. (1992). Fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9, 199-213.
39. Mello, N. K., Lukas, S. E., & Mendelson, J. H. (1985). Buprenorphine effects on cigarette smoking. Psychopharmacology, 86, 417-425.
40. Mello, N. K., Mendelson, J. H., Sellers, M. L., & Kuehnle, J. C. (1980). Effects of heroin self-administration on cigarette smoking. Psychopharmacology, 67, 45-52.
41. Minnes, S., Lang, A., & Singer, L. (2011). Prenatal tobacco, marijuana, stimulant, and opiate exposure: Outcomes and practice implications. Addiction Science and Clinical Practice, 6, 57-70.
42. Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of death in the united states, 2000. JAMA: The Journal of the American Medical Association, 291, 1238-1245. doi:10.1001/jama.291.10.1238
43. Mutschler, N. H., Stephen, B. J., Teoh, S. K., Mendelson, J. H., & Mello, N. K. (2002). An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids. Nicotine & Tobacco Research, 4, 223-228. doi:10.1080/14622200210124012
44. Nahvi, S., Richter, K., Li, X., Modali, L., & Arnsten, J. (2006). Cigarette smoking and interest in quitting in methadone maintenance patients. Addictive Behaviors, 31, 2127-2134. doi:10.1016/j.addbeh.2006.01.006
45. Office of the Surgeon General (US) & Office on Smoking and Health (US). (2004). 2004 Surgeon General's Report-The Health Consequences of Smoking. Retrieved from http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm
46. Pajusco, B., Chiamulera, C., Quaglio, G., Moro, L., Casari, R., Amen, G., . . . Lugoboni, L. (2012). Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. International Journal of Environmental Research and Public Health, 9, 932-942.
47. Richter, K. P., & Ahluwalia, J. S. (2000). A case for addressing cigarette use in methadone and other opioid treatment programs. Journal of Addictive Diseases, 19, 35-52.
48. Richter, K. P., & Arnsten, J. H. (2006). A rationale and model for addressing tobacco dependence in substance abuse treatment. Substance Abuse Treatment, Prevention, and Policy, 1, 23. doi:10.1186/1747-597X-1-23
49. Richter, K. P., Gibson, C. A., Ahluwalia, J. S., & Schmelzle, K. H. (2001). Tobacco use and quit attempts among methadone maintenance clients. American Journal of Public Health, 91, 296-299.
50. Salihu, H. M., Sharma, P. P., Getahun, D., Hedayatzadeh, M., Peters, S., Kirby, R. S., . . . Gaafer-Ahmed, H. (2008). Prenatal tobacco use and risk of stillbirth: A case-control and bidirectional case-crossover study. Nicotine & Tobacco Research, 10, 159-166. doi:10.1080/14622200701705431
51. Stroud, L. R., Paster, R. L., Papandonatos, G. D., Niaura, R., Salisbury, A. L., Battle, C., . . . Lester, B. (2009). Maternal smoking during pregnancy and newborn neurobehavior: Effects at 10 to 27 days. Journal of Pediatrics, 154, 10-16. doi:10.1016/j.jpeds.2008.07.048
52. Thiriez, G., Bouhaddi, M., Mourot, L., Nobili, F., Fortrat, J. O., Menget, A., . . . Regnard, J. (2009). Heart rate variability in preterm infants and maternal smoking during pregnancy. Clinical Autonomic Research, 19, 149-156. doi:10.1007/ s10286-009-0003-8
53. Tong, V. T., Jones, J. R., Dietz, P. M., D'Angelo, D., Bombard, J. M., & Centers for Disease Control and Prevention (CDC). (2009). Trends in smoking before, during, and after pregnancy - pregnancy risk assessment monitoring system (PRAMS), united states, 31 sites, 2000-2005. MMWR.Surveillance Summaries: Morbidity and Mortality Weekly Report.Surveillance Summaries/ CDC, 58, 1-29.
54. Tuten, M., Fitzsimons, H., Chisolm, M. S., Nuzzo, P. A., & Jones, H. E. (2012). Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: Results of an initial feasibility and efficacy randomized clinical trial. Addiction, 107, 1868-1877. doi:10.1111/j.1360- 0443.2012.03923.x; 10.1111/j.1360-0443.2012.03923.x
55. U.S. Preventive Services Task Force. (2009). Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. preventive services task force reaffirmation recommendation statement. Annals of Internal Medicine, 150, 551-555.
56. Winklbaur, B., Baewert, A., Jagsch, R., Rohrmeister, K., Metz, V., Aeschbach Jachmann, C., . . . Fischer, G. (2009). Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. European Addiction Research, 15, 150-156. doi:10.1159/000216466
57. World Health Organization. (2010). World No Tobacco Day- May 31, 2010: Women are huge potential market for the tobacco industry. Retrieved from http://www.euro.who.int/en/what-we-publish/information-for-the-media/sections/latestpress-releases/world-no-tobacco-day-may-31,-2010-womenare-huge-potential-market-for-the-tobacco-industry